London medical cannabis firm acquires "major" Spanish production facility

A UK medical cannabis company has announced that it has acquired a “major” production facility in Spain as it expands globally.

Grow, based in London, has acquired Sanoid Isolates, a medical cannabis production facility in Spain.

The acquisition will transform Grow into an integrated cannabis production, R&D, and distribution company.

The facility, in Seville, includes eight hectares of sustainable & low-cost sun-grown production capacity, inclusive of four hectares of fully constructed high-tech greenhouses.

Ben Langley, CEO of Grow, commented: “This acquisition showcases our ambition to become Europe’s leading supplier of cannabis medicines, creating an efficient supply chain from farm right through to pharmacy, to better serve thousands of patients.

“It will allow us to produce new cannabis medicines that the market needs, while giving us the infrastructure to carry out production and extraction efficiently and cheaply.

“The deal not only solidifies our ability to produce medicines for those patients we support in the UK, but will also support us as we expand globally.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.